Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures
- PMID: 26447889
- PMCID: PMC4890629
- DOI: 10.1111/jgs.13807
Alternative Medications for Medications in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug-Disease Interactions in the Elderly Quality Measures
Abstract
The National Committee for Quality Assurance (NCQA) and the Pharmacy Quality Alliance (PQA) use the American Geriatrics Society (AGS) Beers Criteria to designate the quality measure Use of High-Risk Medications in the Elderly (HRM). The Centers for Medicare and Medicaid Services (CMS) use the HRM measure to monitor and evaluate the quality of care provided to Medicare beneficiaries. NCQA additionally uses the AGS Beers Criteria to designate the quality measure Potentially Harmful Drug-Disease Interactions in the Elderly. Medications included in these measures may be harmful to elderly adults and negatively affect a healthcare plan's quality ratings. Prescribers, pharmacists, patients, and healthcare plans may benefit from evidence-based alternative medication treatments to avoid these problems. Therefore the goal of this work was to develop a list of alternative medications to those included in the two measures. The authors conducted a comprehensive literature review from 2000 to 2015 and a search of their personal files. From the evidence, they prepared a list of drug-therapy alternatives with supporting references. A reference list of nonpharmacological approaches was also provided when appropriate. NCQA, PQA, the 2015 AGS Beers Criteria panel, and the Executive Committee of the AGS reviewed the drug therapy alternatives and nonpharmacological approaches. Recommendations by these groups were incorporated into the final list of alternatives. The final product of drug-therapy alternatives to medications included in the two quality measures and some nonpharmacological resources will be useful to health professionals, consumers, payers, and health systems that care for older adults.
Keywords: Beers Criteria; inappropriate medications; medication management.
© 2015, Copyright the Authors Journal compilation © 2015, The American Geriatrics Society.
Conflict of interest statement
Conflict of Interest: The editor in chief has reviewed the conflict of interest checklist provided by the authors and has determined that the authors have no financial or any other kind of personal conflicts with this paper. Todd P. Semla receives honoraria from the AGS and LexiComp, Inc. He is a member of Omnicare, Inc. Pharmacy and Therapeutics Committee (consultant). His spouse is an employee of AbbVie and owns stock in AbbVie, Abbott Labs, and Hospira.
Similar articles
-
American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults.J Am Geriatr Soc. 2015 Nov;63(11):2227-46. doi: 10.1111/jgs.13702. Epub 2015 Oct 8. J Am Geriatr Soc. 2015. PMID: 26446832
-
Use of 2015 Beers Criteria Medications by Older Medicare Beneficiaries.Consult Pharm. 2018 Jan 1;33(1):48-54. doi: 10.4140/TCP.n.2018.48. Consult Pharm. 2018. PMID: 29336278
-
Highlights From the 2019 AGS Beers Criteria® Updates.Sr Care Pharm. 2020 Feb 1;35(2):68-74. doi: 10.4140/TCP.n.2019.68. Sr Care Pharm. 2020. PMID: 32019641
-
A Closer Look at the 2015 Beers Criteria.J Pharm Pract. 2017 Aug;30(4):419-424. doi: 10.1177/0897190016663072. Epub 2016 Sep 6. J Pharm Pract. 2017. PMID: 27599749 Review.
-
Inappropriate prescribing for the elderly: beers criteria-based review.Ann Pharmacother. 2000 Mar;34(3):338-46. doi: 10.1345/aph.19006. Ann Pharmacother. 2000. PMID: 10917382 Review.
Cited by
-
Polypharmacy and potentially inappropriate medicine use in older adults with cancer: a multicenter cross-sectional study in Northwest Ethiopia oncologic centers.J Pharm Policy Pract. 2024 Oct 1;17(1):2397797. doi: 10.1080/20523211.2024.2397797. eCollection 2024. J Pharm Policy Pract. 2024. PMID: 39359864 Free PMC article.
-
Polypharmacy and potentially inappropriate prescribing of benzodiazepines in older nursing home residents.Ann Med. 2024 Dec;56(1):2357232. doi: 10.1080/07853890.2024.2357232. Epub 2024 Jun 4. Ann Med. 2024. PMID: 38833339 Free PMC article.
-
Cumulative Anticholinergic Burden and its Predictors among Older Adults with Alzheimer's Disease Initiating Cholinesterase Inhibitors.Drugs Aging. 2024 Apr;41(4):339-355. doi: 10.1007/s40266-024-01103-2. Epub 2024 Mar 11. Drugs Aging. 2024. PMID: 38467994
-
The (Mis)use of Psychotropic Drugs and Addiction to Anxiolytics among Older Adults Living at Home or in Retirement Homes: Implications for Quality of Life.Healthcare (Basel). 2023 Nov 6;11(21):2908. doi: 10.3390/healthcare11212908. Healthcare (Basel). 2023. PMID: 37958052 Free PMC article.
-
Delirium and Delirium Prevention in the Emergency Department.Clin Geriatr Med. 2023 Nov;39(4):535-551. doi: 10.1016/j.cger.2023.05.006. Epub 2023 Jun 14. Clin Geriatr Med. 2023. PMID: 37798064 Free PMC article. Review.
References
-
- Huisman-Baron M, van der Veen L, Jansen PAF, et al. Criteria for drug selection in frail elderly persons. Drugs Aging. 2011;28:391–402. - PubMed
-
- NCQA. [Accessed April 23, 2015];HEDIS 2015 Final NDC Lists [on-line] Available at http://www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures/HEDIS2015/HEDI....
-
- Shrank WH, Polinski JM, Avorn J. Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007;55:S373–S382. - PubMed
APPENDIX I. References for Alternative Medications Included in Table 1
-
- Hansen J, Klimek L, Hörmann K. Pharmacological management of allergic rhinitis in the elderly: Safety issues with oral antihistamines. Drugs Aging. 2005;22:289–296. - PubMed
-
- Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008;63(Suppl 86):8–160. - PubMed
-
- Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol. 2008;122(Suppl 2):S1–S84. - PubMed
APPENDIX II. References for Alternative Medications Included in Table 2
-
- Correll CM, Bazil CW. Management of seizures in the elderly. Curr Geri Rep. 2014;3:73–82.
-
- Werhahn KJ, et al. A randomized, double-blind comparison of antiepileptic drug treatment in the elderly with new-onset focal epilepsy. Epilepsia. 2015;56:450–459. - PubMed
-
- Dworkin RH, O’Connor AB, Backonja M, et al. Pharmacologic management of neuropathic pain: Evidence-based recommendations. Pain. 2007;132:237–251. - PubMed
APPENDIX III. Resources for Nonpharmacological Alternatives to Medications Included in the Use of High-Risk Medications in the Elderly and Potentially Harmful Drug–Disease Interactions in the Elderly Quality Measures
-
- Holroyd-Leduc J, Reddy M, editors. Evidence-Based Geriatric Medicine. BMJ Books; 2012.
-
- Reuben DB, Herr KA, Pacala JT, et al. Geriatrics at Your Fingertips: 2015. 17. New York: American Geriatrics Society; 2015.
-
- Durso SC, Sullivan GM, editors. Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine. 8. New York: American Geriatrics Society; 2013.
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
